1Horlitz M, Sigwart U, Niebauer J. Fighting restenosis after coronary angioplasty: contemporary and future treatment options [ J ]. Int J Cardiol. 2002, 83(3): 199～205.
2Bayes - Genis A, Conover CA, Schwartz RS. The insulin - like growth factor axis: a review of atherosclerosis and restenosis [ J ].Circ Res. 2000, 86(2) : 125 ～ 130.
3Maile LA, Clemmons DR. Regulation of insulin - like growth factor Ⅰ receptor dephosphorylation by SHPS - 1 and the tyrosine phosphatase SHP - 2 [ J ]. J Biol Chem. 2002, 277 ( 11 ) : 8955 ～ 8960.
4Maile LA, Clemmons DR. Integrin - associated protein binding domain of thrombospondin - 1 enhances insulin - like growth factor - Ⅰ receptor signaling in vascular smooth muscle cells [ J ]. Circ Res.2003, 93(10) : 925 ～ 931.
5Firth SM, Baxter RC. Cellular actions of the insulin - like growth factor binding proteins [ J ]. Endocr Rev. 2002, 23 (6) : 824 ～ 854.
7Delafontaine P, Song YH, Li Y. Expression, regulation, and function of IGF-1, IGF-1 R, and IGF-1 binding proteins in blood vessels[J]. Arterioscler Thromb Vase Biol. 2004, 24(3) : 435 ～ 444.
8Che W, Lerner - Marmarosh N, Huang Q, et al. Insulin - like growth factor- 1 enhances inflammatory responses in endothelial cells: role of Gabl and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression [ J ]. Circ Res. 2002. 90(11 ) : 1222 ～ 1230.
2[1]Ross R.The pathogenesis of atherosclerosis:a perspective for the 1990s [J].Nature. 1993,326:801 ～ 809
3[2]S trauss BH,Chisholm RJ, Keeley FW,et al. Extracellulr matrix remodelingafter balloon angioplasty injury in a rabbit model of restenosis [J]. Circ Res.1994,75:650～ 658
4[3]Bormstein P. Thrombospondins: structure and regulation of expression[J].FASEB J. 1992,6:3290～ 3299
5[4]May J Reed, Luisa Iruela-Arispe, Edward R, et al. Expression of Thrombospondins by Endothelial Cells [J].Am J Pathol. 1995,4:147
6[5]Asoh AS, Bamwell J, Silverstein RL,et al. Isolation of the thrombospondinmembrane receptor [J]. J Clin Invest. 1987,79:1054～1067
7[6]Chung J,Gao A-G, Frazier WA. Thrombospondin acts via integrin-associatedprotein to activate the platelet integrin α Ⅱ Bβ3 [J]. J Biol Chem. 1997,272:14740～ 14746
8[7]Greenoalt DE, Lipsky RH, Ockenhouse CF, et al. Membrane glycoproteinCD36:a review of its roles in adherence, signal transduction, and transfusionmedicine [J]. Blood. 1992,80:1105 ～ 1115
9[8]Dawson DW, Pearce SF, Zhong R, et al. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells [J] . J Cell Biol.1997, 138(3) :707～ 717
10[9]Qian X, Wang TN, Rothman VL, et al. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells [J]. Exp Cell Res.1997,235(2) :403 ～ 412
1Hayry P, Aavik E, Myllarniemi M. Blockade of growth factor synthesis and growth factor action: two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury [ J ]. Metabolism, 1996,45 (8 Suppl 1 ) : 101 - 103
2Lipke EA, West JL. Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model[ J ]. Acta Biomater,2005,1 (6) : 597 - 606
3Lim H J, Park HY, Ko YG, et al. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis [ J ]. Biochem Biophys Res Commun, 2004,325(3) :1106 - 1114
4Mitra AK, Agrawal DK. In stent restenosis: bane of the stent era [J]. J Clin Pathol,2006,59(3) :232-239
5Delafontaine P, Song YH, Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels [J]. Arterioscler Thromb Vasc Biol, 2004,24(3) :435-444
6Zimmermann O, Zwaka TP, Marx N, et al. Serum starvation and growth factor receptor expression in vascular smooth muscle cells [J]. J Vasc Res,2006, 43(2):157-165
7Stawowy P, Kallisch H, Kilinmik A, et al. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metaUoproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor [ J ]. Biochem Biophys Res Commun, 2004,321 (3) :531-538
